Skip to main content
. 2018 Feb 21;18(2):1–160.

Table 33:

Estimated Annual Per-Patient Costs of Continuous Glucose Monitoring when Insulin Pump, Insulin, and 75% of Sensor Costs Are Publicly Funded

Intervention Technology Year 1, $ Year 2, $ Year 3, $ Year 4, $ Year 5, $
Comparators
SMBG + multiple daily injections 2,329 2,692 2,952 3,134 3,251
SMBG + insulin pump Animas Vibe 1,599 1,963 2,234 2,432 2,566
Interventions
CGM + multiple daily injections Dexcom G4/G5 6,889a 7,240a 7,389a 7,461a 7,465a
CGM + insulin pump Integrated 5,542b 5,893b 6,058b 6,157b 6,194b
SAP with LGS MiniMed Veo 3,406 3,725 3,959 4,112 4,199
SAP or SAP with LGS 10% SAP; 90% SAP with LGS 3,619 3,942 4,169 4,317 4,399
Average CGM device 40% CGM + multiple daily injections; 60% CGM + SAP 4,927 5,261 5,457 5,574 5,625

Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend [feature]; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose.

a

Average cost of Dexcom G4 Platinum and Dexcom G5 Mobile.

b

Average cost of Dexcom G4 Platinum + Animas Vibe and Dexcom G5 Mobile + Animas Vibe.